8 | Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022
-
01/2011 |
7 | ZymosanIBA
01/2012
-
03/2004 |
6 | Proteins (Proteins, Gene)FDA Link
01/2020
-
07/2004 |
6 | Formaldehyde (Formol)FDA Link
09/2011
-
03/2003 |
5 | Analgesics (Analgesic Drugs)IBA
01/2021
-
12/2009 |
5 | Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2019
-
08/2008 |
3 | Potassium Channels (Potassium Channel)IBA
02/2024
-
01/2019 |
3 | EnzymesIBA
01/2023
-
03/2013 |
3 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2022
-
03/2013 |
3 | AntioxidantsIBA
12/2013
-
01/2011 |
3 | Cyclic GMP-Dependent Protein Kinase Type IIBA
08/2008
-
03/2004 |
2 | Guanylate Cyclase (Guanylyl Cyclase)IBA
06/2023
-
08/2008 |
2 | Soluble Guanylyl CyclaseIBA
06/2023
-
03/2019 |
2 | Protein Isoforms (Isoforms)IBA
06/2022
-
03/2019 |
2 | Superoxides (Superoxide)IBA
06/2022
-
03/2013 |
2 | NADPH Oxidases (NAD(P)H oxidase)IBA
06/2022
-
03/2013 |
2 | Capsaicin (Zostrix)FDA Link
01/2022
-
01/2022 |
2 | Opioid Analgesics (Opioids)IBA
10/2021
-
04/2003 |
2 | Pregabalin (Lyrica)FDA Link
01/2021
-
12/2009 |
2 | Monomeric GTP-Binding ProteinsIBA
01/2020
-
01/2017 |
2 | Cysteine (L-Cysteine)FDA Link
01/2020
-
02/2008 |
2 | Loxapine (Loxitane)FDA LinkGeneric
01/2019
-
01/2015 |
2 | Guanosine Monophosphate (5' Guanylic Acid)IBA
10/2014
-
08/2014 |
2 | Messenger RNA (mRNA)IBA
12/2013
-
09/2011 |
2 | Protein Kinases (Protein Kinase)IBA
09/2011
-
03/2003 |
2 | Glutamic Acid (Glutamate)FDA Link
10/2008
-
05/2005 |
2 | Synapsins (Synapsin I)IBA
10/2008
-
05/2005 |
2 | NF-kappa B (NF-kB)IBA
03/2007
-
02/2007 |
1 | Histamine (Histamine Dihydrochloride)FDA Link
02/2024 |
1 | CollagenIBA
06/2023 |
1 | Bleomycin (Blenoxane)FDA LinkGeneric
06/2023 |
1 | allyl isothiocyanateIBA
01/2022 |
1 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 |
1 | CalciumIBA
10/2021 |
1 | Adenosine A1 ReceptorIBA
01/2021 |
1 | NADPH Oxidase 4IBA
01/2021 |
1 | capadenosonIBA
01/2021 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
01/2021 |
1 | Epoxide HydrolasesIBA
01/2020 |
1 | NucleotidesIBA
01/2020 |
1 | LigandsIBA
01/2020 |
1 | Serine (L-Serine)FDA Link
01/2020 |
1 | Dopamine (Intropin)FDA LinkGeneric
01/2019 |
1 | Histamine Receptors (Histamine Receptor)IBA
01/2019 |
1 | Antipsychotic Agents (Antipsychotics)IBA
01/2019 |
1 | CytokinesIBA
01/2019 |
1 | narciclasineIBA
01/2019 |
1 | Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA
10/2017 |
1 | ProteomeIBA
01/2017 |
1 | Hydrogen Sulfide (Sulfide, Hydrogen)IBA
10/2015 |
1 | LyasesIBA
10/2015 |
1 | CystathionineIBA
10/2015 |
1 | Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
10/2014 |
1 | Oxidants (Oxidizing Agents)IBA
10/2014 |
1 | Purinergic Receptors (Receptors, Purine)IBA
09/2014 |
1 | N,N''- 1,4- butanediylbis(N'- (3- isothiocyanatophenyl))thioureaIBA
09/2014 |
1 | purinoceptor P2Y6IBA
09/2014 |
1 | Cyclic NucleotidesIBA
08/2014 |
1 | 2- (3,4- dimethoxybenzyl)- 7- (1- (1- hydroxyethyl)- 4- phenylbutyl)- 5- methylimidazo(5,1- f)(1,2,4)triazin- 4 (3H)-oneIBA
08/2014 |
1 | Type 2 Cyclic Nucleotide PhosphodiesterasesIBA
08/2014 |
1 | Adenosine Monophosphate (AMP)IBA
08/2014 |
1 | NS 1619IBA
03/2014 |
1 | Activating Transcription Factor 3IBA
12/2013 |
1 | tert-ButylhydroperoxideIBA
12/2013 |
1 | TamoxifenFDA LinkGeneric
07/2012 |
1 | NADP (NADPH)IBA
07/2012 |
1 | 5,6-epoxy-8,11,14-eicosatrienoic acidIBA
05/2012 |
1 | Glycine Receptors (Glycine Receptor)IBA
01/2012 |
1 | Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2011 |
1 | Vitamin EFDA LinkGeneric
01/2011 |
1 | Freund's AdjuvantIBA
01/2011 |
1 | VitaminsIBA
01/2011 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
05/2010 |